Dermatitis News

The European Medicines Agency has validated the marketing authorization application for delgocitinib cream for moderate to severe chronic hand eczema treatment, LEO Pharma announced in a press release.

Atopic dermatitis was associated with increased odds for schizophrenia and schizoaffective disorder, according to a study published in Archives of Dermatological Research.

Arcutis Biotherapeutics and Hangzhou Zhongmei Huadong Pharmaceutical Co. have entered into a strategic collaboration and licensing agreement to develop and commercialize Zoryve in China and Southeast Asia, according to a press release.

Positive top-line results from two phase 3 studies show remibrutinib yielded statistically significant improvements in disease severity among patients with chronic spontaneous urticaria, Novartis announced in a press release.

Zerigo Health has appointed Lisa Rometty as its new CEO, according to a company release.

Pediatric patients with atopic dermatitis whose pruritus has not been successfully controlled with topical treatments have seen success with nemolizumab, according to a study.

The high discordance of disease severity grading between patients and physicians calls for targeted interventions and more compassionate health care approaches, according to a study.

Sexually diverse individuals are at an increased risk for atopic diseases, including asthma, allergic rhinitis and atopic dermatitis, according to a research letter.

In this edition, lack of sunless tanner education may cause confusion; intralesional HPV vaccine may clear recalcitrant warts; Ilumetri improves well-being of patients with plaque psoriasis and more.

CHICAGO — By protecting the skin barrier against atopic dermatitis, physicians may prevent food allergy as well, according to a presentation at the Global Food Allergy Prevention Summit.